Rodríguez-Antigüedad, J, Olmedo-Saura, G, Pagonabarraga, J, Martínez-Horta, S, Kulisevsky, J. Approaches for treating neuropsychiatric symptoms in Parkinson's disease: a narrative review. Therapeutic Advances in Neurological Disorders. 2025; 18DOI:10.1177/17562864251336903. PMID:40433403. IF:4.100(Q1/2D).

Portella, MJ, Arteaga-Henríquez, G, de Diego-Adeliño, J, Trujols, J, Puigdemont, D, Pérez, J, Alemany, C, Carrasco-Hernández, J, Udina, M, Cardoner, N, Vicent-Gil, M. Linking cognitive function and biological markers in depression: Can IL-6 plasma levels and attention domain be used as an ensemble classification system?. GENERAL HOSPITAL PSYCHIATRY. 2025; 92DOI:10.1016/j.genhosppsych.2024.10.003. PMID:39395857. IF:3.700(Q1/3D).

Seppälä, J, Grasa, E, Alonso-Solis, A, Roldan-Bejarano, A, Haapea, M, Isohanni, M, Miettunen, J, Mendivelso, JC, Almazán, C, Rubinstein, K, Caspi, A, Unoka, Z, Farkas, K, Reixach, E, Berdun, J, Usall, J, Ochoa, S, Corripio, I, Jääskeläinen, E. Mobile Therapeutic Attention for Treatment-Resistant Schizophrenia (m-RESIST) Solution for Improving Clinical and Functional Outcomes in Treatment-Resistant Schizophrenia: Prospective, Multicenter Efficacy Study. Jmir Human Factors. 2025; 12DOI:10.2196/67659. PMID:40372941. IF:(Q/D).

Lhoëst, MTL, Martínez, A, Garcia, E, Dandurand, J, Polishchuk, A, Benitez-Amaro, A, Cenarro, A, Civeira, F, Bernabé, A, Vilades, D, Escolà-Gil, JC, Samouillan, V, Llorente-Cortes, V. ApoB100 remodeling and stiffened cholesteryl ester core raise LDL aggregation in familial hypercholesterolemia patients. JOURNAL OF LIPID RESEARCH. 2025; 66(1)DOI:10.1016/j.jlr.2024.100703. PMID:39557294. IF:4.100(Q2/4D).